Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Front-line”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05048615
What this trial is testing

Low-dose Venetoclax and Azacitidine as Front-line Therapy in Newly Diagnosed AML

Who this might be right for
AML
Hospital Universitario Dr. Jose E. Gonzalez 15
Testing effectiveness (Phase 2)Ended earlyNCT01193868
What this trial is testing

RO4929097 in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Recently Completed Treatment With Front-Line Chemotherapy

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT05478512
What this trial is testing

Front-line VenObi Combination Followed by Ven or VenZan Combination in Patients With Residual Disease: a MRD Tailored Treatment for Young Patients With High-risk CLL

Who this might be right for
High Risk CLLChronic Lymphocytic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 78
Large-scale testing (Phase 3)Study completedNCT03939637
What this trial is testing

Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

Who this might be right for
Immune Thrombocytopenia
Baylor College of Medicine 122
Testing effectiveness (Phase 2)Study completedNCT02981303
What this trial is testing

Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer

Who this might be right for
Advanced MelanomaTriple-Negative Breast Cancer
HiberCell, Inc. 64
Not applicableUnknownNCT02981420
What this trial is testing

Implementing a Brief Suicide Intervention for High Risk Youth With Front-Line Juvenile Justice Staff

Who this might be right for
Suicide and Self Harm
Rhode Island Hospital 300
Post-approval studies (Phase 4)Study completedNCT00770588
What this trial is testing

Assess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (Stage IIIB/IV) Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
AstraZeneca 296
Testing effectiveness (Phase 2)WithdrawnNCT05879484
What this trial is testing

Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS

Who this might be right for
Sinonasal CancerSquamous Non-small Cell Lung CancerLung Cancer+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT05183984
What this trial is testing

Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian Cancer

Who this might be right for
Ovarian Cancer
ARCAGY/ GINECO GROUP 390
Testing effectiveness (Phase 2)Active Not RecruitingNCT03198026
What this trial is testing

Obinutuzumab and Ibrutinib as Front Line Therapy in Treating Patients With Indolent Non-Hodgkin's Lymphomas

Who this might be right for
Non-Hodgkin's LymphomaAnn Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueAnn Arbor Stage II Follicular Lymphoma+16 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 29
Testing effectiveness (Phase 2)UnknownNCT03410784
What this trial is testing

Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Who this might be right for
Ovarian Cancer
National Cancer Institute, Naples 72
Not applicableLooking for participantsNCT06249347
What this trial is testing

Left Roof Linear, Mitral Isthmus Linear and Left Anterior Septal Linear Ablation for Non-paroxysmal AF: PROMISED Trial.

Who this might be right for
Atrial FibrillationAtrial Fibrillation, Persistent
Second Affiliated Hospital of Wenzhou Medical University 166
Testing effectiveness (Phase 2)Study completedNCT02232386
What this trial is testing

Phase 2 Study to Assess Activity & Safety of Front-line Ibrutinib + Rituximab in Unfit Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocyte LeukemiaAdult Patients
Gruppo Italiano Malattie EMatologiche dell'Adulto 156
Testing effectiveness (Phase 2)Ended earlyNCT00995488
What this trial is testing

Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer

Who this might be right for
Urothelial CancerBladder Cancer
University of Michigan Rogel Cancer Center 16
Early research (Phase 1)Study completedNCT01309789
What this trial is testing

Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell Neoplasms

Who this might be right for
Lymphoma, Large-Cell, AnaplasticLymphoma, NK-cellLymphoma, T-cell
Seagen Inc. 39
Testing effectiveness (Phase 2)UnknownNCT02744768
What this trial is testing

D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 60
Testing effectiveness (Phase 2)Ended earlyNCT01508117
What this trial is testing

Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients

Who this might be right for
Glioblastoma Multiforme
University of Cincinnati 1
Not applicableStudy completedNCT03721289
What this trial is testing

Evaluation in Real World of Molecular Testing and Treatment Patterns for EGFR Mutation in Lung Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 463
Testing effectiveness (Phase 2)WithdrawnNCT05239910
What this trial is testing

Study to Evaluate the Efficacy and Safety of Tenalisib, Given With CHOP Therapy for Front Line Treatment in Patients With PTCL

Who this might be right for
Peripheral T Cell Lymphoma
Rhizen Pharmaceuticals SA
Not applicableStudy completedNCT01655329
What this trial is testing

Reader Study to Demonstrate That Use of ClearRead Confirm is Superior to the Use Standard AP/PA X-ray Image

Who this might be right for
Catheters, With or Without MalpositionImage Interpretation, Computer Assisted
Georgetown University 10
Next Page